Astrazeneca press release. Sep 19, 2025 · Stay up to date with all latest press releases from AstraZeneca PLC (AZN). , September 26, 2025--AstraZeneca today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access Sep 17, 2025 · AstraZeneca Media centre. May 16, 2024 · AstraZeneca AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. With more than 75 abstracts, including eight late-breakers, the Company continues to drive innovation and address unmet needs in care across all Jun 1, 2025 · AstraZeneca in breast cancer Driven by a growing understanding of breast cancer biology, AstraZeneca is challenging, and redefining, the current clinical paradigm for how breast cancer is classified and treated to deliver even more effective treatments to patients in need – with the bold ambition to one day eliminate breast cancer as a cause Apr 11, 2024 · Additional indication for pediatric patients with severe eosinophilic asthma AstraZeneca’s FASENRA ® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on maintenance treatment for patients with severe asthma aged 6 to 11 with an eosinophilic phenotype. With more than 75 abstracts, including eight Mar 13, 2024 · AstraZeneca in Respiratory & Immunology Respiratory & Immunology, part of AstraZeneca BioPharmaceuticals is a key disease area and growth driver to the Company. Feb 6, 2024 · AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critical cancer trials and future commercial supply. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its . It is against AstraZeneca policy to provide a list of our vendors to members of the media. May 13, 2025 · AstraZeneca will present the latest clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Society (ATS) International Conference, in San Francisco, CA from 16 to 21 May 2025. The trial Sep 9, 2024 · AstraZeneca was one of the first seven companies globally to have its net zero targets verified by the Science-Based Targets initiative (SBTi) Corporate Net-Zero Standard. oehvcy wj mfgc 3q nurn mwyp dge ngvj0 4rlt x4c